NeoGenomics Closes $34.6M Public Offering | GenomeWeb

NEW YORK (GenomeWeb) – NeoGenomics today announced the closing of a public offering that raised $34.6 million in net proceeds.

The Ft. Myers, Fla.-based cancer genetic testing services firm offered 8.05 million shares at $4.60 per share, which included 1.05 million shares purchased by the underwriters on the offering as a result of the exercise of their overallotment option.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.